ARTICLE | Company News

Martek, Abbott, Bristol-Myers sales and marketing update

January 14, 2002 8:00 AM UTC

ABT's Ross Products Division plans to launch in the U.S. early this year an infant formula that contains MATK's docosahexaenoic acid (DHA) and arachidonic acid (ARA), long-chain polyunsaturated fatty acids. ABT has a non-exclusive license to ARA and DHA under a 2000 deal (see BioCentury, April 10, 2000). ...